IgG Subclasses and Allotypes: From Structure to Effector Functions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schur, 1988, IgG subclasses. A historical perspective, Monogr Allergy, 23, 1
Bruhns, 2009, Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses, Blood, 113, 3716, 10.1182/blood-2008-09-179754
Pan, 2000, Molecular basis of IgG subclass deficiency, Immunol Rev, 178, 99, 10.1034/j.1600-065X.2000.17815.x
Vlug, 1994, Nephelometric measurements of human IgG subclasses and their reference ranges, Ann Biol Clin (Paris), 52, 561
Pone, 2012, BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kappaB pathway, Nat Commun, 3, 767, 10.1038/ncomms1769
Pone, 2010, Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses, Crit Rev Immunol, 30, 1, 10.1615/CritRevImmunol.v30.i1.10
Berkowska, 2011, Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways, Blood, 118, 2150, 10.1182/blood-2011-04-345579
Aalberse, 2009, Immunoglobulin G4: an odd antibody, Clin Exp Allergy, 39, 469, 10.1111/j.1365-2222.2009.03207.x
Ferrante, 1990, IgG subclass distribution of antibodies to bacterial and viral antigens, Pediatr Infect Dis J, 9, S16, 10.1097/00006454-199008001-00004
Jefferis, 1990, Selective IgG subclass deficiency: quantification and clinical relevance, Clin Exp Immunol, 81, 357, 10.1111/j.1365-2249.1990.tb05339.x
Siber, 1980, Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens, N Engl J Med, 303, 178, 10.1056/NEJM198007243030402
Barrett, 1986, IgG2 subclass restriction of antibody to pneumococcal polysaccharides, Clin Exp Immunol, 63, 127
Schauer, 2003, Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults, Clin Diagn Lab Immunol, 10, 202, 10.1128/CDLI.10.2.202-207.2003
Hammarstrom, 1983, IgG2 deficiency in a healthy blood donor. Concomitant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies, Clin Exp Immunol, 51, 600
Hammarstrom, 1987, Subclass restriction pattern of antigen-specific antibodies in donors with defective expression of IgG or IgA subclass heavy chain constant region genes, Clin Immunol Immunopathol, 45, 461, 10.1016/0090-1229(87)90097-3
Kuijpers, 1992, IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens, Allergol Immunopathol (Madr), 20, 28
Latiff, 2007, The clinical significance of immunoglobulin A deficiency, Ann Clin Biochem, 44, 131, 10.1258/000456307780117993
von Gunten, 2009, Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass, J Allergy Clin Immunol, 123, 1268, 10.1016/j.jaci.2009.03.013
Vidarsson, 1998, Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine, Infect Immun, 66, 2866, 10.1128/IAI.66.6.2866-2870.1998
Stapleton, 2011, Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential, Nat Commun, 2, 599, 10.1038/ncomms1608
Seppala, 1993, Low concentrations of Gm allotypic subsets G3 mg and G1 mf in homozygotes and heterozygotes, J Immunol, 151, 2529, 10.4049/jimmunol.151.5.2529
Hassan, 1992, Regulation of C gamma 3 expression. Role of switch in the allotype-associated variation of human serum IgG3 levels, J Immunol, 148, 2555, 10.4049/jimmunol.148.8.2555
Brezski, 2010, Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?, MAbs, 2, 212, 10.4161/mabs.2.3.11780
Soderstrom, 1985, Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group, J Immunol, 134, 1, 10.4049/jimmunol.134.1.1
Brouwers, 1988, Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn, Br J Haematol, 70, 465, 10.1111/j.1365-2141.1988.tb02518.x
Mawas, 1997, Immunoglobulin G subclasses of anti-human platelet antigen 1a in maternal sera: relation to the severity of neonatal alloimmune thrombocytopenia, Eur J Haematol, 59, 287, 10.1111/j.1600-0609.1997.tb01688.x
Pollock, 1990, Anti-Rh (D) IgG subclasses and severity of Rh hemolytic disease of the newborn, Vox Sang, 59, 176, 10.1111/j.1423-0410.1990.tb00854.x
Meyts, 2006, Isolated IgG3 deficiency in children: to treat or not to treat? Case presentation and review of the literature, Pediatr Allergy Immunol, 17, 544, 10.1111/j.1399-3038.2006.00454.x
Aalberse, 1983, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response, J Immunol, 130, 722, 10.4049/jimmunol.130.2.722
Nouri-Aria, 2004, Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity, J Immunol, 172, 3252, 10.4049/jimmunol.172.5.3252
Jutel, 2011, Immunological mechanisms of allergen-specific immunotherapy, Allergy, 66, 725, 10.1111/j.1398-9995.2011.02589.x
van Helden, 2008, IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A, Br J Haematol, 142, 644, 10.1111/j.1365-2141.2008.07232.x
Andersen, 1968, Gamma G4-globulin antibody causing inhibition of clotting factor VIII, Nature, 217, 174, 10.1038/217174a0
Iizuka, 1983, Analysis of IgG heavy chain subclasses of alloantibodies to factor IX by crossed immunoelectrophoresis of factor IX using the intermediate gel technique, Br J Haematol, 53, 687, 10.1111/j.1365-2141.1983.tb07323.x
van Schouwenburg, 2012, IgG4 Production Against Adalimumab During Long Term Treatment of RA Patients, J Clin Immunol, 32, 1000, 10.1007/s10875-012-9705-0
Ottesen, 1985, Prominence of IgG4 in the IgG antibody response to human filariasis, J Immunol, 134, 2707, 10.4049/jimmunol.134.4.2707
Adjobimey, 2010, Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation, Ann Trop Med Parasitol, 104, 455, 10.1179/136485910X12786389891407
Kurniawan, 1993, Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis, J Immunol, 150, 3941, 10.4049/jimmunol.150.9.3941
Sah, 2011, Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis, Curr Opin Rheumatol, 23, 108, 10.1097/BOR.0b013e3283413469
Yamamoto, 2012, Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases, Mod Rheumatol, 22, 419, 10.1007/s10165-011-0532-6
Potter, 1983, Structural correlates of immunoglobulin diversity, Surv Immunol Res, 2, 27, 10.1007/BF02918394
Kabat, 1978, Variable region genes for the immunoglobulin framework are assembled from small segments of DNA – a hypothesis, Proc Natl Acad Sci U S A, 75, 2429, 10.1073/pnas.75.5.2429
Ferrara, 2011, Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc{gamma}RIII and antibodies lacking core fucose, Proc Natl Acad Sci U S A, 108, 12669, 10.1073/pnas.1108455108
Radaev, 2001, The structure of a human type III Fcgamma receptor in complex with Fc, J Biol Chem, 276, 16469, 10.1074/jbc.M100350200
Kato, 2000, Structural basis of the interaction between IgG and Fcgamma receptors, J Mol Biol, 295, 213, 10.1006/jmbi.1999.3351
Radaev, 2002, Recognition of immunoglobulins by Fcgamma receptors, Mol Immunol, 38, 1073, 10.1016/S0161-5890(02)00036-6
Sondermann, 2013, General mechanism for modulating immunoglobulin effector function, Proc Natl Acad Sci U S A, 110, 9868, 10.1073/pnas.1307864110
West, 2000, Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor (,), Biochemistry, 39, 9698, 10.1021/bi000749m
Burmeister, 1994, Crystal structure of the complex of rat neonatal Fc receptor with Fc, Nature, 372, 379, 10.1038/372379a0
Keeble, 2008, TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved, Proc Natl Acad Sci U S A, 105, 6045, 10.1073/pnas.0800159105
Kapur, 2014, A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy, Blood, 123, 471, 10.1182/blood-2013-09-527978
Wuhrer, 2009, Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens, J Proteome Res, 8, 450, 10.1021/pr800651j
Wright, 1991, Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure, EMBO J, 10, 2717, 10.1002/j.1460-2075.1991.tb07819.x
Ackerman, 2013, Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity, J Clin Invest, 123, 2183, 10.1172/JCI65708DS1
Guhr, 2011, Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia, PLoS One, 6, e21246, 10.1371/journal.pone.0021246
Stadlmann, 2009, A close look at human IgG sialylation and subclass distribution after lectin fractionation, Proteomics, 9, 4143, 10.1002/pmic.200800931
Radcliffe, 2007, Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor, J Biol Chem, 282, 7405, 10.1074/jbc.M602690200
Hamilton, 1987, Human IgG subclass measurements in the clinical laboratory, Clin Chem, 33, 1707, 10.1093/clinchem/33.10.1707
Michaelsen, 1993, Human IgG3 is decreased and IgG1, IgG2 and IgG4 are unchanged in molecular size by mild reduction and reoxidation without any major change in effector functions, Mol Immunol, 30, 35, 10.1016/0161-5890(93)90424-A
Saluk, 1971, The unique molecular weight of the heavy chain from human IgG3, J Immunol, 107, 298, 10.4049/jimmunol.107.1.298
Carrasco, 2001, Crystallohydrodynamics for solving the hydration problem for multi-domain proteins: open physiological conformations for human IgG, Biophys Chem, 93, 181, 10.1016/S0301-4622(01)00220-4
Wypych, 2008, Human IgG2 antibodies display disulfide-mediated structural isoforms, J Biol Chem, 283, 16194, 10.1074/jbc.M709987200
Zhang, 2010, Determination of Fab-hinge disulfide connectivity in structural isoforms of a recombinant human immunoglobulin G2 antibody, Anal Chem, 82, 1090, 10.1021/ac902466z
Dillon, 2008, Structural and functional characterization of disulfide isoforms of the human IgG2 subclass, J Biol Chem, 283, 16206, 10.1074/jbc.M709988200
Lightle, 2010, Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding, Protein Sci, 19, 753, 10.1002/pro.352
Chivers, 1997, The CXXC motif: a rheostat in the active site, Biochemistry, 36, 4061, 10.1021/bi9628580
Bloom, 1997, Intrachain disulfide bond in the core hinge region of human IgG4, Protein Sci, 6, 407, 10.1002/pro.5560060217
Angal, 1993, A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody, Mol Immunol, 30, 105, 10.1016/0161-5890(93)90432-B
Rispens, 2011, Mechanism of immunoglobulin G4 Fab-arm exchange, J Am Chem Soc, 133, 10302, 10.1021/ja203638y
Van der Zee, 1986, Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency, J Immunol, 137, 3566, 10.4049/jimmunol.137.11.3566
van der Neut, 2007, Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange, Science, 317, 1554, 10.1126/science.1144603
Rispens, 2014, Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange, J Biol Chem, 289, 6098, 10.1074/jbc.M113.541813
Labrijn, 2011, Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength, J Immunol, 187, 3238, 10.4049/jimmunol.1003336
Labrijn, 2009, Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo, Nat Biotechnol, 27, 767, 10.1038/nbt.1553
Lefranc, 2012, Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism, Methods Mol Biol, 882, 635, 10.1007/978-1-61779-842-9_34
de Lange, 1989, Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes, Exp Clin Immunogenet, 6, 7
Jefferis, 2009, Human immunoglobulin allotypes: possible implications for immunogenicity, MAbs, 1, 332, 10.4161/mabs.1.4.9122
Dard, 2001, DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations, Eur J Hum Genet, 9, 765, 10.1038/sj.ejhg.5200700
Brusco, 1998, Molecular characterization of immunoglobulin G4 gene isoallotypes, Eur J Immunogenet, 25, 349, 10.1111/j.1744-313X.1998.tb01152.x
Brusco, 1995, Molecular characterization of Gm (n+) and G2m (n-) allotypes, Immunogenetics, 42, 414, 10.1007/BF00179404
Fudenberg, 1964, Antibody to hereditary human gamma-globulin (Gm) factor resulting from maternal-fetal incompatibility, Science, 145, 170, 10.1126/science.145.3628.170
de Lange, 1985, Immunoglobulin allotypes in a Chinese population: comparison of haplotype frequencies with other Asian groups, J Immunogenet, 12, 191, 10.1111/j.1744-313X.1985.tb00846.x
Goetze, 2011, Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood, Mol Immunol, 49, 338, 10.1016/j.molimm.2011.09.002
Cook, 1979, An amino acid substitution in the gamma 1 chain of human immunoglobulin G associated with the Gm (2) allotype, Mol Immunol, 16, 555, 10.1016/0161-5890(79)90117-2
Heilig, 2003, The DNA sequence and analysis of human chromosome 14, Nature, 421, 601, 10.1038/nature01348
Hougs, 2003, Three new alleles of IGHG2 and their prevalence in Danish Caucasians, Mozambican Blacks and Japanese, Tissue Antigens, 61, 231, 10.1034/j.1399-0039.2003.00048.x
Bartelds, 2010, Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study 1, Arthritis Res Ther, 12, R221, 10.1186/ar3208
Magdelaine-Beuzelin, 2009, IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab 8, Pharmacogenet Genomics, 19, 383, 10.1097/FPC.0b013e32832a06bf
Morell, 1972, Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera, J Immunol, 108, 195, 10.4049/jimmunol.108.1.195
Iserentant, 1980, Secondary structure of mRNA and efficiency of translation initiation, Gene, 9, 1, 10.1016/0378-1119(80)90163-8
Mao, 2014, Deciphering the rules by which dynamics of mRNA secondary structure affect translation efficiency in Saccharomyces cerevisiae, Nucleic Acids Res, 42, 4813, 10.1093/nar/gku159
Pan, 2000, An allotype-associated polymorphism in the gamma3 promoter determines the germ-line gamma3 transcriptional rate but does not influence switching and subsequent IgG3 production, Eur J Immunol, 30, 2388, 10.1002/1521-4141(2000)30:82388::AID-IMMU23883.0.CO;2-C
Diebolder, 2014, Complement is activated by IgG hexamers assembled at the cell surface, Science, 343, 1260, 10.1126/science.1248943
Zauner, 2013, Glycoproteomic analysis of antibodies, Mol Cell Proteomics, 12, 856, 10.1074/mcp.R112.026005
Parekh, 1985, Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature, 316, 452, 10.1038/316452a0
Bondt, 2014, IgG Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes, Mol Cell Proteomics, 10.1074/mcp.M114.039537
Kapur, 2014, Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn, Br J Haematol, 166, 936, 10.1111/bjh.12965
Menni, 2013, Glycosylation of immunoglobulin g: role of genetic and epigenetic influences, PLoS One, 8, e82558, 10.1371/journal.pone.0082558
Chen, 2012, Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer, J Proteomics, 75, 2824, 10.1016/j.jprot.2012.02.001
Wang, 2011, Fc-glycosylation of IgG1 is modulated by B-cell stimuli, Mol Cell Proteomics, 10, M110, 10.1074/mcp.M110.004655
Prados, 2011, Progesterone induces a switch in oligosaccharyltransferase isoform expression: consequences on IgG N-glycosylation, Immunol Lett, 137, 28, 10.1016/j.imlet.2011.01.017
Bowden, 2012, Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis, J Am Chem Soc, 134, 17554, 10.1021/ja306068g
Mimura, 2001, Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding, J Biol Chem, 276, 45539, 10.1074/jbc.M107478200
Sondermann, 2000, The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex, Nature, 406, 267, 10.1038/35018508
Mizushima, 2011, Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans, Genes Cells, 16, 1071, 10.1111/j.1365-2443.2011.01552.x
Shields, 2002, Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity, J Biol Chem, 277, 26733, 10.1074/jbc.M202069200
Yamane-Ohnuki, 2009, Production of therapeutic antibodies with controlled fucosylation, MAbs, 1, 230, 10.4161/mabs.1.3.8328
Jefferis, 2009, Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action, Trends Pharmacol Sci, 30, 356, 10.1016/j.tips.2009.04.007
Shibata-Koyama, 2009, Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils, Exp Hematol, 37, 309, 10.1016/j.exphem.2008.11.006
Peipp, 2008, Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells, Blood, 112, 2390, 10.1182/blood-2008-03-144600
Selman, 2012, Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination, Mol Cell Proteomics, 11, M111, 10.1074/mcp.M111.014563
Kodar, 2012, Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival, Glycoconj J, 29, 57, 10.1007/s10719-011-9364-z
Zou, 2011, Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcgammaIIIa receptor, J Am Chem Soc, 133, 18975, 10.1021/ja208390n
Bakovic, 2013, High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides, J Proteome Res, 12, 821, 10.1021/pr300887z
Ferrara, 2006, Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II, Biotechnol Bioeng, 93, 851, 10.1002/bit.20777
Kapur, 2014, IgG-effector functions: “the good, the bad and the uglyâ€, Immunol Lett, 160, 139, 10.1016/j.imlet.2014.01.015
Bondt, 2013, Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation, J Proteome Res, 12, 4522, 10.1021/pr400589m
Ahmed, 2014, Structural characterization of anti-inflammatory immunoglobulin g fc proteins, J Mol Biol, 426, 3166, 10.1016/j.jmb.2014.07.006
Kaneko, 2006, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, 313, 670, 10.1126/science.1129594
Anthony, 2008, Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc, Science, 320, 373, 10.1126/science.1154315
Bindon, 1988, Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q, J Exp Med, 168, 127, 10.1084/jem.168.1.127
Schumaker, 1976, Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement, Biochemistry, 15, 5175, 10.1021/bi00668a035
Tao, 1993, Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation, J Exp Med, 178, 661, 10.1084/jem.178.2.661
Idusogie, 2000, Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc, J Immunol, 164, 4178, 10.4049/jimmunol.164.8.4178
Morgan, 1995, The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding, Immunology, 86, 319
Brekke, 1994, Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis, Eur J Immunol, 24, 2542, 10.1002/eji.1830241042
Dall’Acqua, 2006, Modulation of the effector functions of a human IgG1 through engineering of its hinge region, J Immunol, 177, 1129, 10.4049/jimmunol.177.2.1129
Dangl, 1988, Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies, EMBO J, 7, 1989, 10.1002/j.1460-2075.1988.tb03037.x
Lu, 2007, Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation, Biophys J, 93, 3733, 10.1529/biophysj.107.108993
Tan, 1990, Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins, Proc Natl Acad Sci U S A, 87, 162, 10.1073/pnas.87.1.162
Natsume, 2008, Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities, Cancer Res, 68, 3863, 10.1158/0008-5472.CAN-07-6297
Abe, 2010, Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy 1, Biochem J, 432, 101, 10.1042/BJ20100641
Van der Zee, 1986, Inhibition of complement activation by IgG4 antibodies, Clin Exp Immunol, 64, 415
Saeland, 2003, Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice, J Immunol, 170, 6158, 10.4049/jimmunol.170.12.6158
Vidarsson, 1994, Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae, J Infect Dis, 170, 592, 10.1093/infdis/170.3.592
Ramsland, 2011, Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes, J Immunol, 187, 3208, 10.4049/jimmunol.1101467
Guilliams, 2014, The function of Fc receptors in dendritic cells and macrophages, Nat Rev Immunol, 14, 94, 10.1038/nri3582
Ernst, 1992, Three genes for the human high affinity Fc receptor for IgG (Fc gamma RI) encode four distinct transcription products, J Biol Chem, 267, 15692, 10.1016/S0021-9258(19)49591-4
Ernst, 1998, Molecular characterization of six variant Fcgamma receptor class I (CD64) transcripts, Mol Immunol, 35, 943, 10.1016/S0161-5890(98)00079-0
Hulett, 1998, The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a, Mol Immunol, 35, 989, 10.1016/S0161-5890(98)00069-8
Canfield, 1991, The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region, J Exp Med, 173, 1483, 10.1084/jem.173.6.1483
Chappel, 1991, Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies, Proc Natl Acad Sci U S A, 88, 9036, 10.1073/pnas.88.20.9036
Shields, 2001, High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R, J Biol Chem, 276, 6591, 10.1074/jbc.M009483200
Lund, 1991, Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG, J Immunol, 147, 2657, 10.4049/jimmunol.147.8.2657
Armour, 1999, Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities, Eur J Immunol, 29, 2613, 10.1002/(SICI)1521-4141(199908)29:082613::AID-IMMU26133.0.CO;2-J
Redpath, 1998, The influence of the hinge region length in binding of human IgG to human Fcgamma receptors, Hum Immunol, 59, 720, 10.1016/S0198-8859(98)00075-5
Parren, 1992, On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2, J Clin Invest, 90, 1537, 10.1172/JCI116022
Armour, 2003, Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies, Mol Immunol, 40, 585, 10.1016/j.molimm.2003.08.004
Wines, 2000, The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A, J Immunol, 164, 5313, 10.4049/jimmunol.164.10.5313
van der Heijden, 2012, Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles, J Immunol, 188, 1318, 10.4049/jimmunol.1003945
Breunis, 2008, Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura, Blood, 111, 1029, 10.1182/blood-2007-03-079913
Li, 2006, Optimization of humanized IgGs in glycoengineered Pichia pastoris, Nat Biotechnol, 24, 210, 10.1038/nbt1178
Siberil, 2006, Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions, Clin Immunol, 118, 170, 10.1016/j.clim.2005.10.008
Huizinga, 1990, Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16), Blood, 75, 213, 10.1182/blood.V75.1.213.213
Huizinga, 1989, Binding characteristics of dimeric IgG subclass complexes to human neutrophils, J Immunol, 142, 2359, 10.4049/jimmunol.142.7.2359
Brambell, 1964, A theoretical model of gamma-globulin catabolism, Nature, 203, 1352, 10.1038/2031352a0
Brambell, 1966, The transmission of immunity from mother to young and the catabolism of immunoglobulins, Lancet, 2, 1087, 10.1016/S0140-6736(66)92190-8
Ghetie, 1996, Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice, Eur J Immunol, 26, 690, 10.1002/eji.1830260327
Israel, 1996, Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn, Immunology, 89, 573, 10.1046/j.1365-2567.1996.d01-775.x
Junghans, 1996, The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor, Proc Natl Acad Sci U S A, 93, 5512, 10.1073/pnas.93.11.5512
Roopenian, 2003, The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs, J Immunol, 170, 3528, 10.4049/jimmunol.170.7.3528
Chaudhury, 2003, The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan, J Biol Chem, 197, 315, 10.1084/jem.20021829
Gastinel, 1992, Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules, Proc Natl Acad Sci U S A, 89, 638, 10.1073/pnas.89.2.638
Einarsdottir, 2014, H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn, Transfusion, 54, 665, 10.1111/trf.12334
Anderson, 2006, Perspective – FcRn transports albumin: relevance to immunology and medicine, Trends Immunol, 27, 343, 10.1016/j.it.2006.05.004
Borvak, 1998, Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice, Int Immunol, 10, 1289, 10.1093/intimm/10.9.1289
Akilesh, 2007, Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism, J Immunol, 179, 4580, 10.4049/jimmunol.179.7.4580
Kacskovics, 2011, Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies, MAbs, 3, 431, 10.4161/mabs.3.5.17023
Yoshida, 2004, Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells, Immunity, 20, 769, 10.1016/j.immuni.2004.05.007
Israel, 1995, Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice, J Immunol, 154, 6246, 10.4049/jimmunol.154.12.6246
Israel, 1997, Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells, Immunology, 92, 69, 10.1046/j.1365-2567.1997.00326.x
Ladinsky, 2012, Electron tomography of late stages of FcRn-mediated antibody transcytosis in neonatal rat small intestine, Mol Biol Cell, 23, 2537, 10.1091/mbc.E12-02-0093
Spiekermann, 2002, Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung, J Exp Med, 196, 303, 10.1084/jem.20020400
Claypool, 2004, Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor, Mol Biol Cell, 15, 1746, 10.1091/mbc.E03-11-0832
Dickinson, 1999, Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line, J Clin Invest, 104, 903, 10.1172/JCI6968
Shah, 2003, Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine, Pediatr Res, 53, 295, 10.1203/01.PDR.0000047663.81816.E3
Caram-Salas, 2011, In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood-brain barrier, Methods Mol Biol, 763, 383, 10.1007/978-1-61779-191-8_26
Robert-Guroff, 2000, IgG surfaces as an important component in mucosal protection, Nat Med, 6, 129, 10.1038/72206
Yoshida, 2006, Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria, J Clin Invest, 116, 2142, 10.1172/JCI27821.2142
Horton, 2013, Antibodies and their receptors: different potential roles in mucosal defense, Front Immunol, 4, 200, 10.3389/fimmu.2013.00200
Zhu, 2001, MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells, J Immunol, 166, 3266, 10.4049/jimmunol.166.5.3266
Cervenak, 2011, Neonatal FcR overexpression boosts humoral immune response in transgenic mice, J Immunol, 186, 959, 10.4049/jimmunol.1000353
Vidarsson, 2006, FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis, Blood, 108, 3573, 10.1182/blood-2006-05-024539
Baker, 2011, Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells, Proc Natl Acad Sci U S A, 108, 9927, 10.1073/pnas.1019037108
Mi, 2008, Targeting the neonatal Fc receptor for antigen delivery using engineered Fc fragments, J Immunol, 181, 7550, 10.4049/jimmunol.181.11.7550
Qiao, 2008, Dependence of antibody-mediated presentation of antigen on FcRn, Proc Natl Acad Sci U S A, 105, 9337, 10.1073/pnas.0801717105
Heijnen, 1996, Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice, J Clin Invest, 97, 331, 10.1172/JCI118420
Ehrhardt, 2003, The inhibitory potential of Fc receptor homolog 4 on memory B cells, Proc Natl Acad Sci U S A, 100, 13489, 10.1073/pnas.1935944100
Haga, 2007, Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment, Proc Natl Acad Sci U S A, 104, 9770, 10.1073/pnas.0703354104
Polson, 2006, Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia, Int Immunol, 18, 1363, 10.1093/intimm/dxl069
Ehrhardt, 2005, Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells, J Exp Med, 202, 783, 10.1084/jem.20050879
Frank, 1993, The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms, Am J Hum Genet, 52, 183
Yang, 2000, Autoantigen Ro52 directly interacts with human IgG heavy chain in vivo in mammalian cells, Mol Immunol, 37, 591, 10.1016/S0161-5890(00)00068-7
Rhodes, 2007, TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain, Mol Immunol, 44, 2406, 10.1016/j.molimm.2006.10.013
Vaysburd, 2013, Intracellular antibody receptor TRIM21 prevents fatal viral infection, Proc Natl Acad Sci U S A, 110, 12397, 10.1073/pnas.1301918110
Watkinson, 2013, Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21, J Virol, 87, 7309, 10.1128/JVI.00647-13
Rakebrandt, 2014, Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica, Pathog Dis, 10.1111/2049-632X.12192
Mallery, 2010, Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21), Proc Natl Acad Sci U S A, 107, 19985, 10.1073/pnas.1014074107
McEwan, 2011, Intracellular antibody-mediated immunity and the role of TRIM21, Bioessays, 33, 803, 10.1002/bies.201100093
McEwan, 2013, Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21, Nat Immunol, 14, 327, 10.1038/ni.2548
Anthony, 2011, Intravenous gammaglobulin suppresses inflammation through a novel T (H)2 pathway, Nature, 475, 110, 10.1038/nature10134
Anthony, 2008, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci U S A, 105, 19571, 10.1073/pnas.0810163105
Massoud, 2014, Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells, J Allergy Clin Immunol, 133, 853, 10.1016/j.jaci.2013.09.029
Yu, 2013, Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain, J Mol Biol, 425, 1253, 10.1016/j.jmb.2013.02.006
von Gunten, 2006, Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations, Blood, 108, 4255, 10.1182/blood-2006-05-021568
von Gunten, 2007, Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies, J Allergy Clin Immunol, 119, 1005, 10.1016/j.jaci.2007.01.023
Seite, 2010, IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes, Blood, 116, 1698, 10.1182/blood-2009-12-261461